ORIGINAL RESEARCH article
Front. Glob. Women’s Health
Sec. Aging in Women
Volume 6 - 2025 | doi: 10.3389/fgwh.2025.1638428
Treatment provision and management for the menopause: a multinational survey study
Provisionally accepted
- University of Cambridge, Cambridge, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Despite available safe hormonal and non-hormonal interventions, most women with troublesome menopausal symptoms do not receive effective, evidence-based therapy, with notable international disparities in provision. This study aimed to investigate self-reported menopausal care experiences in a self-selecting sample from five English-speaking countries: Australia, Canada, New Zealand, the United Kingdom, and the United States, through an anonymous online survey. The 15-20 minute survey, delivered via Qualtrics XM®, included questions on sociodemographic characteristics and treatment experiences, such as the number of healthcare professionals (HCP) seen before getting a prescription, ease of obtaining treatment, involvement in treatment discussions, appropriateness of treatment review and optimization, side effect tolerability, and overall satisfaction. Data from 3,062 respondents were analyzed: Australia (16.59%, n=508), Canada (17.54%, n=537), New Zealand (16.59%, n=508), UK (24.00%, n=735), and US (25.28%, n=774). Significant international differences were observed in both healthcare access and prescribing patterns. More women in the UK and US consulted an HCP compared with Australia, Canada, and New Zealand (χ²(4, N=3062)=101.02, p<0.001, φc=0.18). Prescription rates were higher in New Zealand, the UK, and the US compared with Australia and Canada (χ²(4, N=2485)=75.71, p<0.001, φc=0.18). However, UK respondents, despite longer treatment use, generally reported less involvement in treatment discussions, poorer treatment review, lower side effect tolerability, and reduced satisfaction compared with other countries across treatment types. Based on a self-selected cohort, these findings reveal critical gaps in menopause care, including disparities in treatment access and international differences in patient involvement. Greater access to healthcare in the UK and the US did not translate into higher satisfaction, highlighting the need for patient-centered approaches. Improving care requires better clinician education and strategies to enhance communication and shared decision-making.
Keywords: Menopause, Patient-Centered Care, Health Services Accessibility, Patient Satisfaction, Menopausal treatment, Healthcare experiences, healthcare interactions
Received: 30 May 2025; Accepted: 15 Oct 2025.
Copyright: © 2025 Martin-Key, Funnell and Bahn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sabine Bahn, sb209@cam.ac.uk
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.